News

What is the main cause of myocardial infarction A cardiologist explains how atherosclerosis and blood clots trigger heart ...
In the field of invasive treatment of coronary artery disease (CAD), the past two decades have been characterised by the ...
BACKGROUND: Direct reprogramming of fibroblasts to cardiomyocytes is a potentially curative strategy for ischemic heart ...
For younger acute myocardial infarction (AMI) survivors, living in marginalized neighborhoods is associated with adverse ...
When discussing heart health, the words 'myocardial infarction' and 'heart attack' are used interchangeably as if they are ...
Secondary analysis findings from the EMPACT-MI trial highlight empagliflozin's significant cardiovascular and kidney benefits when initiated soon after an acute myocardial infarction.
Because Canada has a universal healthcare system, financial differences in access to care cannot fully explain the observed ...
In an exclusive chat with Deccan Chronicle, Kshemavana’s Chief Wellness Officer warns against drug abuse, nutraceutical ...
The triggering receptor expressed on myeloid cells 2 (TREM2) plays a pivotal role in the activation of myeloid cells and is currently being investigated as a potential therapeutic target in several ...
New data shows no increased cardiovascular risk of the osteoporosis drug vs anabolic agents — and even suggests a lower risk.
UC Davis Medical Center earned four awards from the American Heart Association for its optimal care for heart and stroke patients.
For patients with acute MI at increased risk for HF, empagliflozin showed cardiorenal benefits and was safe to initiate early ...